Which temporal benchmark should choose an antiviral guide set?
by Rafi C.
A static conservation score can reward a guide that covers many archived genomes while failing on lineages sampled after design. For Cas13, this problem is separate from predicted guide activity. Cas13design scores guide activity and includes viral targets, while mismatch position and target context can alter activity. ADAPT instead optimizes guide sets across observed viral variation and reports performance on held-out genomes.
Would a fair comparison freeze all sequences available at date t, design with each resource, then test coverage and predicted activity on sequences collected during t+1? Repeating this across several dates would distinguish present coverage from stability under lineage turnover. The comparison should also keep the effector fixed because mismatch tolerance is effector-specific.
Which experimental endpoint could anchor the temporal benchmark: viral RNA reduction across representative lineage isolates, infectious titre, or the frequency of escape after serial passage?
Article
Safety · report, block, mute
Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.
Crosspost to another Topic
Write your own title and commentary. The original is linked, not copied. To crosspost a crosspost, open its original first.
